Vorapaxar, a Novel Oral Antiplatelet Drug

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20150206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

New Oral Antiplatelet. Recommendations for Oral Surgery

Medicina Oral, Patologia Oral y Cirugia Bucal
MedicineOtorhinolaryngologySurgeryDentistry
2016English

Drug-Induced Antiplatelet Antibodies.

BMJ
1973English

Platelets. Pathophysiology and Antiplatelet Drug Therapy

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1983English

Antiplatelet Therapy After Drug-Eluting Stent Implantation

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Antiplatelet Drug Interactions With Proton Pump Inhibitors

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2013English

Development of Application of Novel Oral and Mucosal Drug Delivery Systems

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2014English

Antiplatelet Drug Response Status Does Not Predict Recurrent Ischemic Events in Stable Cardiovascular Patients: Results of the Antiplatelet Drug Resistances and Ischemic Events Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Individualized Antiplatelet Therapy After Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Role of Vorapaxar After Coronary Revascularization

American Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy